大叶牛奶菜孕甾甙成分研究

用硅胶层析及反相硅胶层析法，从大叶牛奶菜（MarsdeniakoiTsiang）抗生育活性的甲醇提取物中分离获得一孕甾四糖甙。经化学反应，波谱分析，酸碱降解及其水解产物的鉴定，确定其结构为12-0-cvnnamyl-dihydrosarcostin-3-0-β-D-glucopyranosyl（l→4）-0-3-0-methyl-6-deoxy-β-D-allopyranosyl(1→4)-0-β-D-oleandropyranosyl(1→4)-0-β-D-cymaropyranoside,命名为大叶牛奶菜甙庚（marsdekoisideG）。经系统文献检索证明其为首次自该植物中分离得到。     

亲电性对醌二甲烷与富电子烯烃的电荷转移聚合

概述了亲电性对醌二甲烷与富电子烯烃电荷转移聚合的最新进展，着重介绍聚合的一般特征、引发机理、链增长机理，以及单体结构、溶剂对聚合反应的影响。     

Albumin recovery enhancement in membrane plasma fractionation using pulsatile flow

In therapeutic plasmapheresis using cascade filtration, it is important to maximize albumin recovery while rejecting as many gamma-globulins as possible. Several membrane fractionation techniques were investigated using fresh bovine and human plasma and cellulose acetate filters (PF 100, AKZO). In dead end mode the sieving coefficients were found to decrease as transmembrane pressure increased. This was due to membrane plugging during the course of filtration after about 20 minutes which lead to a rapid increase in transmembrane pressure. In single pass mode the albumin recovery factor generally remains around 40% since the permeate flux is much less than the inlet flow. When strong pulsations (4 to 6 Hz) were superposed on the inlet plasma flow in single pass mode, the albumin sieving coefficient remained at about 0.95 while the permeate flux was increased by 106%. As a result a recovery factor of more than 80% could be sustained for at least 90 minutes without membrane plugging. Therefore pulsatile flow plasma fractionation seems to be an interesting approach to combine continuous operation with high albumin recovery.     

SEN病毒D亚型ORF1-C端基因的克隆、表达和鉴定

目的:获得SENV-D亚型ORF1-C端蛋白基因序列,并进行表达,为进一步研究及诊断、治疗应用奠定基础.方法:用PCR法从SENV阳性血清中获得SENV-DORF1C端基因,测序验证后,构建了pQE30-SENV-D重组表达质粒,并经过转化E.coli M15,IPTG诱导表达,Western blot分析表达结果.结果:获得了正确序列的SENV-D亚型ORF1-C端蛋白基因序列,表达出Mr约为38×103的蛋白.表达蛋白能与患者血清中相应的抗体结合,发生抗原抗体反应.结论:成功获得并表达了SENV-D-ORF1-C端蛋白,并经Western blot印迹法证实能与阳性血清中的抗体发生抗原抗体反应,有可能用于检测SENV-D抗体.为今后进一步研究有助于疫情监测及早期发现感染者的抗体奠定了坚实的基础.     

C型臂X线机引导下经皮双侧骶髂拉力螺钉固定治疗骶骨H形骨折

目的探讨骶骨H形骨折可行的治疗方法。方法运用C型臂X线机引导下经皮双侧骶髂拉力螺钉固定治疗骶骨H形骨折15例。结果15例患者均获随访，随访时间7—34个月，骨折临床愈合时间3～5个月，术后均未留下明显行走障碍，下蹲等活动接近正常。结论在C型臂X线机精确引导下，经皮双侧骶髂拉力螺钉固定技术能有效地固定骶骨H形骨折中的垂直骨折，纠正骨盆垂直方向移位，操作简洁安全，疗效可靠。     

健康教育对宫颈糜烂妇女治疗依从性的研究

目的 探讨多种形式的健康教育对提高宫颈糜烂治疗依从性的作用。方法 将确诊为宫颈糜烂的120例患者随机分为研究组、对照组。均给予相应的治疗。研究组增加健康教育内容。两组患者同时观察复诊率、治愈率、对医疗服务的满意程度、疾病的认知情况。结果 研究组增加健康教育后，患者复诊率、治愈率、诊疗满意程度、疾病认知情况均较对照组高(P＜O．05)。结论 健康教育能提高宫颈糜烂患者的治疗依从性，获得较高的治愈率。     

夜间电子生物阻抗测量装置对阴茎勃起功能障碍的检测

目的 :探讨夜间电子生物阻抗测量装置 (NEVA)在阴茎勃起功能障碍的诊断中的应用价值。方法 :对 4 1例主诉阴茎勃起功能障碍者 (障碍组 ) 19例主诉无勃起功能障碍但有射精障碍者 (无障碍组 )进行NEVA检测。结果 :障碍组夜间试验中的夜间勃起的次数、阴茎勃起的最大体积改变、最长持续时间等客观指标均要差于无障碍组 ,差异有统计学意义 (P <0 .0 1)。结论 :NEVA为非侵入性检测、可鉴别心理性阴茎勃起功能障碍和严重的器质性勃起功能障碍 ,且对勃起功能障碍的定性和定量具有一定的客观性。     

基于混合遗传算法的心脏病决策支持系统研究

将遗传算法和 BP算法相结合 ,建立了一个基于混合遗传算法的心脏病决策支持系统来鉴别诊断五种常见心脏病 (冠心病 ,高血压性心脏病 ,风湿性心脏病 ,慢性肺原性心脏病和先天性心脏病 )。一个含有 35 2份心脏病的数据库用来构建和测试了该系统。实验结果表明 ,构建的系统对这五种心脏病均有较好的诊断识别率 ,系统的平均识别准确性达 90 .6 % ,各疾病的用户准确性和程序准确性均大于 85 .0 % ,表现出良好的心脏病的临床诊断决策支持能力     

高校科技创新工作的若干问题及对策

我国高等学校的科技队伍不断发展和壮大 ,在我国的科技事业发展中具有举足轻重的地位 ,高等学校的科技创新对推进我国国家创新体系的建设起着越来越重要的作用。但高校科学研究工作中存在一些困难和问题 ,必须采用改革现行管理体制和运行机制等对策予以解决     

Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus.

BACKGROUND: Seroreversion, negativation of anti-hepatitis C virus previously positive, is sometimes found in some chronic hepatitis C-sustained responders (SRs) to antiviral therapy. AIMS: To determine the probability of seroreversion in SR treatment with Interferon and Ribavirin, and lymphocyte T helper (CD4+) reactivity to HCV antigens. METHODS: Thirty SR were followed on average for 54.8 months. Anti-HCV was tested by third generation test. Peripheral blood mononuclear cells (PBMCs) were isolated from venous blood and cultured to evaluate CD4+ proliferation in response to 2 microg/ml of eight HCV recombinant antigens from core, NS3, NS4, NS5 regions. RESULTS: Seroreversion was verified in 23% of patients (7/30), appearing at 47.5+/-24.0 months. The probability of anti-HCV loss in this group was 25% at 56 months after ending therapy. In 57% (4/7), anti-HCV returned to positive. These 7 SR patients with seroreversion also showed weaker CD4+ reactivity in 5% of tests (3/56) than the remaining 23 anti-HCV-positive SRs who showed stronger reactivity in 18% of tests (33/184), P=0.036. CONCLUSIONS: One-quarter of the SR showed seroreversion of anti-HCV and weaker CD4+ specific HCV proliferation than those who remained anti-HCV positive. The data suggest that complete viral eradication is a possible and achievable clinical objective.